NCT05246163 ARTIficial Intelligence-based Smartphone Application for Skin Cancer Detection
| NCT ID | NCT05246163 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Skin Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2025-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2020-01-01 with a primary completion date of 2025-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this project is to assess whether a specific smartphone application (Skinvision App®) can be used as a tool to preselect skin lesions suspicious for skin cancer that require urgent medical advice.
Eligibility Criteria
Inclusion Criteria: * Patients with one or two lesions meeting at least one of the following criteria: * New mole in an adult (\> 18 years old); * 'Ugly duckling' sign (i.e. mole that looks different from other moles in the same person) * Changing mole (size, color, shape or structure); * Rapid growing lesion * Non-healing lesion * Written informed consent of the patient Exclusion Criteria: * Lack of informed consent for study participation
Contact & Investigator
Lieve Brochez, MD, PhD
PRINCIPAL INVESTIGATOR
Ghent University Hospital, Department of Dermatology
Frequently Asked Questions
Who can join the NCT05246163 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Skin Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05246163 currently recruiting?
Yes, NCT05246163 is actively recruiting participants. Contact the research team at julie.kips@ugent.be for enrollment information.
Where is the NCT05246163 trial being conducted?
This trial is being conducted at Ghent, Belgium.
Who is sponsoring the NCT05246163 clinical trial?
NCT05246163 is sponsored by University Hospital, Ghent. The principal investigator is Lieve Brochez, MD, PhD at Ghent University Hospital, Department of Dermatology. The trial plans to enroll 2,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.